AbbVie Inc. is 286.2x more valuable than ARDELYX, INC. by market capitalization ($402.35 B vs $1.41 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARDX | ABBV |
|---|---|---|
| Market cap | $1.41 B | $402.35 B |
| US-listed rank | #2398 | #31 |
| Revenue (latest FY) | $407.32M | $61.16B |
| Net income (latest FY) | -$62.00M | $4.23B |
| Net margin | -15.2% | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 1,143 | 1,008 |
AbbVie Inc. is 286.2x more valuable than ARDELYX, INC. by market capitalization ($402.35 B vs $1.41 B).
In their latest fiscal years, ARDELYX, INC. reported $407.32M in revenue while AbbVie Inc. reported $61.16B.
Full pages: ARDELYX, INC. and AbbVie Inc., or browse the full rankings.